Javascript must be enabled to continue!
Enthalpies of Mixing in the Binary Liquid Systems Alk(Cl–Br), Alk(Cl–I), and Alk(Br–I)
View through CrossRef
The enthalpies of mixing in the A(X–Y) binary liquid alkali halide mixtures have been measured by high-temperature reaction calorimetry (A denotes Li–Cs; X, Y denote Cl, Br, I). All the considered systems have positive enthalpies of mixing with maximum values which range from about +4cal/mole for Cs(Cl–Br) to about +117 cal/mole for Na(Cl–I). The molar enthalpies of mixing can be represented by the semi-empirical relations, Δ HM≅ N1N2Aδ122.In this expression, N1 and N2 are the mole fractions of the two components; δ12=(d1−d2)/d1d2, where d1 and d2 are the interionic distances characteristic of the two salts; A is a constant which for Li as a common cation is about +125 kcal·Å2/mole; for Na, K, Rb, Cs, A ≈ +250 kcal·Å2/mole. An excellent correlation is found between the positive enthalpies of mixing and calculated values derived from estimates of the London-van der Waals' interaction between second-nearest-neighbor anions. However, the observed values are about 5 times larger than the calculated ones. It is possible that this may be due to use of too low values for the characteristic energy in the London expression.
Title: Enthalpies of Mixing in the Binary Liquid Systems Alk(Cl–Br), Alk(Cl–I), and Alk(Br–I)
Description:
The enthalpies of mixing in the A(X–Y) binary liquid alkali halide mixtures have been measured by high-temperature reaction calorimetry (A denotes Li–Cs; X, Y denote Cl, Br, I).
All the considered systems have positive enthalpies of mixing with maximum values which range from about +4cal/mole for Cs(Cl–Br) to about +117 cal/mole for Na(Cl–I).
The molar enthalpies of mixing can be represented by the semi-empirical relations, Δ HM≅ N1N2Aδ122.
In this expression, N1 and N2 are the mole fractions of the two components; δ12=(d1−d2)/d1d2, where d1 and d2 are the interionic distances characteristic of the two salts; A is a constant which for Li as a common cation is about +125 kcal·Å2/mole; for Na, K, Rb, Cs, A ≈ +250 kcal·Å2/mole.
An excellent correlation is found between the positive enthalpies of mixing and calculated values derived from estimates of the London-van der Waals' interaction between second-nearest-neighbor anions.
However, the observed values are about 5 times larger than the calculated ones.
It is possible that this may be due to use of too low values for the characteristic energy in the London expression.
Related Results
The Fusion Landscape of Anaplastic Large Cell Lymphoma: An L.L.M.P.P. Study
The Fusion Landscape of Anaplastic Large Cell Lymphoma: An L.L.M.P.P. Study
Background: Anaplastic large cell lymphomas (ALCLs) represent a heterogeneous group of T-cell lymphomas that currently are classified by the presence or absence of ALK tyrosine kin...
FISH patterns of ROS1, MET, and ALK with a correlation of ALK immunohistochemistry in lung cancer: a case for introducing ALK immunohistochemistry 'Equivocal' interpretation category in the Ventana anti-ALK (D5F3) CDx assay - A tertiary cancer center expe
FISH patterns of ROS1, MET, and ALK with a correlation of ALK immunohistochemistry in lung cancer: a case for introducing ALK immunohistochemistry 'Equivocal' interpretation category in the Ventana anti-ALK (D5F3) CDx assay - A tertiary cancer center expe
Background:
Mutations in ROS1, ALK, and MET genes are targetable alterations in non-small cell lung cancer (NSCLC). They can be evaluated by different techniques, most ...
Abstract 3806: Overcoming drug-tolerant cancer cell subpopulations showing AXL activation and epithelial-mesenchymal transition is critical in conquering ALK-positive lung cancer
Abstract 3806: Overcoming drug-tolerant cancer cell subpopulations showing AXL activation and epithelial-mesenchymal transition is critical in conquering ALK-positive lung cancer
Abstract
Anaplastic lymphoma kinase tyrosine kinase inhibitors (ALK-TKIs) induce a dramatic response in non-small cell lung cancer (NSCLC) patients with the ALK fusi...
Concomitant novel ALK-SSH2, EML4-ALK and ARID2-ALK, EML4-ALK double-fusion variants and confer sensitivity to crizotinib in two lung adenocarcinoma patients, respectively
Concomitant novel ALK-SSH2, EML4-ALK and ARID2-ALK, EML4-ALK double-fusion variants and confer sensitivity to crizotinib in two lung adenocarcinoma patients, respectively
Abstract
Introduction
Anaplastic lymphoma kinase (ALK) gene rearrangements, have been identified in approximately 2-7% of patients with lung adenoca...
Abstract 3036: ALK protein expression and its prognostic significance in MYCN non amplified neuroblastoma
Abstract 3036: ALK protein expression and its prognostic significance in MYCN non amplified neuroblastoma
Abstract
Anaplastic lymphoma kinase (ALK) point mutations (within the kinase domain), gene amplification and protein overexpression are identified (8-14%) both in fa...
ALK F1174S mutation impairs ALK kinase activity in EML4-ALK variant 1 and sensitizes EML4-ALK variant 3 to crizotinib
ALK F1174S mutation impairs ALK kinase activity in EML4-ALK variant 1 and sensitizes EML4-ALK variant 3 to crizotinib
ObjectiveTo assess the influence of F1174S mutation on kinase activity and drug sensitivity of the echinoderm microtubule-associated protein-like 4 (EML4) and anaplastic lymphoma k...
Abstract B055: XPO1-dependent nuclear export as a therapeutic target for ALK-positive non-small cell lung cancers
Abstract B055: XPO1-dependent nuclear export as a therapeutic target for ALK-positive non-small cell lung cancers
Abstract
EML4-ALK fusion has emerged as a significant oncogenic driver in Non-Small Cell Lung Cancer (NSCLC), promoting ...
Abstract 1788: Preclinical development of a selective, potent small molecule ALK inhibitor
Abstract 1788: Preclinical development of a selective, potent small molecule ALK inhibitor
Abstract
A chromosomal inversion [inv (2)(p21p23)] resulting in the expression of an oncogenic kinase fusion protein known as EML4-ALK [echinoderm microtubule-associ...

